Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells (Q24317197)

GOA release 2020-03-11

blood circulation

1 reference

GOA release 2020-03-11

author name string

T Crass

1

0 references

U Raffetseder

2

0 references

U Martin

3

0 references

M Grove

4

0 references

A Klos

5

0 references

J Köhl

6

0 references

W Bautsch

European Journal of Immunology

7

0 references

language of work or name

English

0 references

publication date

August 1996

0 references

published in

0 references

volume

26

0 references

issue

8

0 references

page(s)

1944-50

0 references

cites work

Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Crystal structure analysis and molecular model of human C3a anaphylatoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

1H NMR studies of human C3a anaphylatoxin in solution: sequential resonance assignments, secondary structure, and global fold

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Reevaluation of the C3a active site using short synthetic C3a analogues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Functional activities of synthetic anaphylatoxic peptides in widely used biological assays

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Synthetic peptides as antagonists of the anaphylatoxin C3a

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Rapid quantification of C3a and C5a using a combination of chromatographic and immunoassay procedures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Peptide analogues of the anaphylatoxin C3a; syntheses and properties.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Ribonucleic acid isolated by cesium chloride centrifugation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

G alpha-16 complements the signal transduction cascade of chemotactic receptors for complement factor C5a (C5a-R) and N-formylated peptides (fMLF-R) in Xenopus laevis oocytes: G alpha-16 couples to chemotactic receptors in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Continuous, on-line DNA sequencing using oligodeoxynucleotide primers with multiple fluorophores

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Selective coupling of the human anaphylatoxin C5a receptor and alpha 16 in human kidney 293 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Human C3a-mediated suppression of the immune response. II. Suppression of human in vitro polyclonal antibody responses occurs through the generation of nonspecific OKT8+ suppressor T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260840

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260840

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

8765043

1 reference

Consolidated OpenCitations Corpus – April 2017